Akorn Vaccine Deal Plants Seed For New Company Direction
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm hopes the distribution deal for a tetanus diphtheria vaccine will pave the way for build-out of its vaccines and biologics business.